Profile: FDA’s Bakul Patel On The Inevitable Future Of Digital Health
Medtech Insight profiles the man leading the US FDA’s digital health efforts to learn about his journey and vision for the future.
You may also be interested in...
Pear has commercialized FDA-cleared prescription digital therapeutics for substance abuse disorder, opioid use disorder and chronic insomnia and has 14 more in development. CEO Corey McCann explained Pear’s vision for how PDTs can transform health care.
Kevin Fu, a University of Michigan associate professor, has been named the US agency’s acting director of medical device cybersecurity. In his new post he’ll be able to mold the agency’s regulatory approach.
Bakul Patel, director of the US agency’s new Digital Health Center of Excellence, tells Medtech Insight he’s looking to hire staff that want to shape the digital health regulatory landscape.